These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chronic angina and the treatment with ranolazine: facts and recommendations. Milne HC; Vallerand AH Prog Cardiovasc Nurs; 2009 Sep; 24(3):90-5. PubMed ID: 19737166 [TBL] [Abstract][Full Text] [Related]
24. Ranolazine: an antianginal drug with antiarrhythmic properties. Tamargo J; Caballero R; Delpón E Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962 [TBL] [Abstract][Full Text] [Related]
25. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina. Tamargo J; Lopez-Sendon J Future Cardiol; 2022 Mar; 18(3):235-251. PubMed ID: 34841884 [TBL] [Abstract][Full Text] [Related]
26. Ranolazine: a review of its use in chronic stable angina pectoris. Keating GM Drugs; 2008; 68(17):2483-503. PubMed ID: 19016575 [TBL] [Abstract][Full Text] [Related]
27. Ranolazine: clinical applications and therapeutic basis. Hawwa N; Menon V Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347 [TBL] [Abstract][Full Text] [Related]
28. Effects of ranolazine on cardiovascular system. Bonadei I; Vizzardi E; Quinzani F; Piovanelli B; Rovetta R; D'Aloia A; Cas LD Recent Pat Cardiovasc Drug Discov; 2011 Sep; 6(3):215-21. PubMed ID: 21867482 [TBL] [Abstract][Full Text] [Related]
30. At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine. Bălan H Rom J Intern Med; 2010; 48(4):361-9. PubMed ID: 21528766 [TBL] [Abstract][Full Text] [Related]
31. Utility of ranolazine in chronic stable angina patients. Patel PD; Arora RR Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998 [TBL] [Abstract][Full Text] [Related]
32. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris. Keating GM Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466 [TBL] [Abstract][Full Text] [Related]
33. Ranolazine: new drug. Stable angina: not worth the risk. Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543 [TBL] [Abstract][Full Text] [Related]
34. Conventional and novel drug therapeutics to relief myocardial ischemia. Dvir D; Battler A Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184 [TBL] [Abstract][Full Text] [Related]
35. Diabetes and coronary disease: a need for new therapies for an expanding disease burden. Lew WY; DeMaria AN J Am Coll Cardiol; 2013 May; 61(20):2046-7. PubMed ID: 23500323 [No Abstract] [Full Text] [Related]
36. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L; J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985 [TBL] [Abstract][Full Text] [Related]
37. Ranolazine: a new option in the management of chronic stable angina. Dobesh PP; Trujillo TC Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887 [TBL] [Abstract][Full Text] [Related]
38. Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina. Arnold SV; Kosiborod M; McGuire DK; Li Y; Yue P; Ben-Yehuda O; Spertus JA JAMA Intern Med; 2014 Aug; 174(8):1403-5. PubMed ID: 24887304 [No Abstract] [Full Text] [Related]